Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Parovis-CR 12.5 Tablet

Prescription Icon
Prescription Required

Marketer

Adivis Pharma Pvt Ltd

Salt Composition

Paroxetine (12.5mg)

Overview Parovis-CR 12.5 Tablet

Sertraline CR 12.5mg tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Prescribed widely for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, these tablets help alleviate depressive symptoms by improving mood and reducing anxiety and tension. This medication can be administered with or without food; dosage and frequency are determined by your physician to optimize symptom management. Your doctor may initiate treatment with a lower dose, gradually increasing it as needed. Never alter your dosage or discontinue use without consulting your physician; abrupt cessation could worsen your condition or trigger unpleasant withdrawal effects (including anxiety, restlessness, rapid heartbeat, dizziness, sleep disturbances, etc.). For maximum effectiveness, take this medication consistently at the same time daily. Morning administration may be recommended if sleep disturbances occur. Significant improvement may take several weeks. Report any lack of progress after four weeks of treatment to your doctor. Common side effects include nausea, tiredness, dry mouth, appetite changes, increased perspiration, lightheadedness, nervousness, trembling, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately inform your doctor of any sudden mood deterioration or suicidal thoughts. Prior to commencing treatment, disclose any pre-existing conditions such as epilepsy, diabetes, liver or kidney impairment, heart disease, or glaucoma, as these may influence treatment. Pregnant or breastfeeding individuals must consult their physician before use. Interactions with other medications, particularly other antidepressants and MAO inhibitors, are possible; always inform your physician of all medications you are currently taking to ensure safety.

Uses of Parovis-CR 12.5 Tablet

Managing depressive disorders | Addressing panic attacks and panic disorder | Anxiety disorder care and management

Major Benefits of Parovis-CR 12.5 Tablet:

Follow your physician's instructions or consult the product labeling for proper administration. Parovis-CR 12.5mg tablets can be ingested with or without food; however, consistent daily timing is recommended.

Common Side effects of Parovis-CR 12.5 Tablet:

  • Nausea
  • Fatigue
  • Dryness in mouth
  • Loss of appetite
  • Increased sweating
  • Dizziness
  • Nervousness
  • Tremors
  • Low sexual desire
  • Insomnia (difficulty in sleeping)
  • Confusion
  • Constipation
  • Erectile dysfunction
  • Delayed ejaculation
  • Decreased libido

How to use Parovis-CR 12.5 Tablet:

Follow your doctor's instructions or consult the product label for proper administration. Parovis-CR 12.5mg tablets can be ingested with or without food; however, consistent daily timing is recommended.

How Parovis-CR 12.5 Tablet works:

Sertraline CR 12.5mg tablets, a selective serotonin reuptake inhibitor (SSRI), elevate brain serotonin levels, a neurotransmitter impacting mood. This mechanism alleviates depressive symptoms, both emotional and physical, and offers relief from panic disorder, anxiety, and obsessive-compulsive disorder.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Parovis-CR 12.5 Tablet is unsafe.

PregnancyPregnancyUNSAFE

Use of Parovis-CR 12.5 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies reveals substantial risks to the fetus.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Parovis-CR 12.5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Parovis-CR 12.5 mg tablets may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should use Parovis-CR 12.5 mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Parovis-CR 12.5 mg tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Parovis-CR 12.5 Tablet :

Should you forget a Parovis-CR 12.5 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Parovis-CR 12.5 Tablet

LabelValue
Type of Compound Piperidine-based phenyl derivative
Addictive None.
Medication Classification Nervous system medication.
Mechanism of Action Serotonin-specific reuptake inhibitors

FAQs on Parovis-CR 12.5 Tablet

Noticeable symptom relief may begin within one to two weeks of commencing treatment. However, if you experience no improvement, continue taking the medication and schedule an appointment with your physician. Complete therapeutic effects might not be apparent for four to six weeks.
Discontinue Parovis-CR 12.5 Tablet only after consulting your physician. Sudden cessation may initially exacerbate symptoms, though improvement typically manifests within one to two weeks. However, if symptoms remain or worsen after this period, seek immediate medical advice.
Parovis-CR 12.5 Tablet use can impact sexual function. Reduced libido and difficulty achieving orgasm are potential side effects for both genders. Furthermore, men may encounter erectile and ejaculatory dysfunction.
Parovis-CR 12.5 Tablets are contraindicated for individuals younger than 18. This age group exhibits a heightened susceptibility to adverse reactions, including suicidal ideation, hostility, defiance, and irritability, following Parovis-CR 12.5 Tablet administration. Should your child's physician have authorized Parovis-CR 12.5 Tablets and concerns regarding these potential side effects arise, consult with the prescribing physician.
Concurrent use of Parovis-CR 12.5 Tablet and tamoxifen is contraindicated. While Parovis-CR 12.5 Tablet can alleviate tamoxifen-induced hot flashes, its concurrent administration diminishes tamoxifen's efficacy and may increase the risk of breast cancer recurrence.
Diabetic patients should exercise caution when using Parovis-CR 12.5 Tablets. This medication can influence blood glucose, potentially requiring adjustments to insulin or other diabetes treatments. Consult your physician for guidance and monitor your blood sugar regularly.
Parovis-CR 12.5 Tablet
111
MRP 135
17% off